(4-((Tetrahydro-2h-pyran-2-yl)methoxy)phenyl)boronic acid, 98%, 1g

4-{[(4-tert-butylphenyl)sulfonyl]amino}benzoic acid, 95.0%, 500mg

4,6-Diphenylpyrimidin-2-amine, 95.0%, 1g

3-allyl-5-ethoxy-4-propoxybenzaldehyde, 95.0%, 5g

1-Isopropoxy-4-nitrobenzene, 95.0%, 5g

(S)-(-)-TolBINAP>98.0%(HPLC)5g

2-tert-Butyl-4-chloro-6-methylpyrimidine, 95.0%, 10g

Accessories intermediate floor HBR 4 control, 1 piece

tert-Butyl spiro[indoline-3,4'-piperidine]-1'-carboxylate, 95.0%, 250mg

4-Cyano-n-methylbenzene-1-sulfonamide, 95%, 1g

(S)-2,2'-Bis[bis(3,5-dimethylphenyl)phosphino]-4,4',6,6'-tetramethoxy)-1,1'-biphenyl, 97%, 250mg

Ethyl 2-(5-bromopyridin-2-yl)-2,2-difluoroacetate, 98%, 100mg

Xanthotoxin, min. 98%, 5 g, glass packaging